220 filings
Page 3 of 11
8-K
6zm7 8ben50xd5o9
5 Aug 22
Ocugen Provides Business Update & Second Quarter 2022 Financial Results
7:35am
8-K
ykx9epcl1ss1e4x
10 Jun 22
Entry into a Material Definitive Agreement
4:37pm
8-K
5s63djlw
7 Jun 22
Submission of Matters to a Vote of Security Holders
4:12pm
8-K
kmgf8b2wtqx3744xh
24 May 22
Ocugen Announces New Cell Therapy Program Following FDA Regenerative Medicine Advanced Therapy (RMAT) Recognition
7:36am
8-K
rya gg3u1be9g
23 May 22
Other Events
9:02am
8-K
j33fd5i5n5aige2q2
6 May 22
Ocugen Provides Business Update and First Quarter 2022 Financial Results
6:44am
8-K
vixs lwoj0x8
20 Apr 22
Other Events
5:11pm
8-K
b31b48g
18 Apr 22
Entry into a Material Definitive Agreement
8:08am
8-K
56ntnwykkcecyjw45
12 Apr 22
Other Events
9:07am
8-K
k7l8njxenmvxonn
4 Apr 22
Other Events
5:01pm
8-K
sjbdowjtuv1 ger
23 Mar 22
Departure of Directors or Certain Officers
7:30am
8-K
zvj shqvy3u
11 Mar 22
Other Events
4:24pm
8-K
fpnb5owpqemt6 6p2u
4 Mar 22
Ocugen Provides an Update on its COVAXIN™ Pediatric (2-18) Emergency Use Authorization (EUA) Request
4:30pm
8-K
ib5gbkvnqmc31m2iu
25 Feb 22
Ocugen Provides Business Update With Fourth Quarter and Full Year 2021 Financial Results
7:41am
8-K
bkhhcvqp10q
25 Feb 22
Entry into a Material Definitive Agreement
7:30am
8-K
40e1yjn5
22 Feb 22
Other Events
7:39am
8-K
o7en5p4qhx9g0sn
22 Feb 22
Other Events
7:36am
8-K
4hcotl7rkcqh8zr
14 Feb 22
Other Events
5:20pm
8-K
hkytxwnjl3ejgv5
2 Feb 22
Other Events
4:50pm
8-K
b942te
28 Jan 22
Unregistered Sales of Equity Securities
4:08pm